APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flu (Influenza) Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Flu (Influenza) Vaccine Industry Growth and Trends Forecast to 2032

2 January 2026109 pages

Choose your research edition.

Industry ResearchFlu (Influenza) Vaccine Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Flu (Influenza) Vaccine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Flu (Influenza) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flu (Influenza) Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Flu (Influenza) Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Flu (Influenza) Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Flu (Influenza) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Flu (Influenza) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Flu (Influenza) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Flu (Influenza) Vaccine include Adimmune, Aimei Hissen, Aleph Biomedical, CCBIO, Changsheng Biological, Hualan Bio, Simcere Vaxtec, SINOVAC and SIOBP, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Flu (Influenza) Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Flu (Influenza) Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Flu (Influenza) Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Flu (Influenza) Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Flu (Influenza) Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Flu (Influenza) Vaccine Market by Company

Adimmune

Aimei Hissen

Aleph Biomedical

CCBIO

Changsheng Biological

Hualan Bio

Simcere Vaxtec

SINOVAC

SIOBP

Tianyuan Bio-pharma(Novartis)

ZYAK

GSK

SANOFI

Flu (Influenza) Vaccine Segment by Type

Subunit Influenza Vaccine

Quadrivalent Influenza Vaccine

Split Influenza Vaccine

Pandemic Influenza Vaccine

Flu (Influenza) Vaccine Segment by Application

For Children (6 months to 3 years)

For Adults and Children over 3 years

Flu (Influenza) Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu (Influenza) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flu (Influenza) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu (Influenza) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Flu (Influenza) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Flu (Influenza) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Subunit Influenza Vaccine Table 2. Major Company of Quadrivalent Influenza Vaccine Table 3. Major Company of Split Influenza Vaccine Table 4. Major Company of Pandemic Influenza Vaccine Table 5. Global Flu (Influenza) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 7. Global Flu (Influenza) Vaccine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Flu (Influenza) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Flu (Influenza) Vaccine Sales Market Share in Value by Type (2021-2026) Table 10. Global Flu (Influenza) Vaccine Price by Type (2021-2026) & (US$/Unit) Table 11. Global Flu (Influenza) Vaccine Sales by Type (2027-2032) & (K Units) Table 12. Global Flu (Influenza) Vaccine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Flu (Influenza) Vaccine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Flu (Influenza) Vaccine Sales Market Share in Value by Type (2027-2032) Table 15. Global Flu (Influenza) Vaccine Price by Type (2027-2032) & (US$/Unit) Table 16. North America Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 17. North America Flu (Influenza) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Europe Flu (Influenza) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Flu (Influenza) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Latin America Flu (Influenza) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Flu (Influenza) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Flu (Influenza) Vaccine Industry Trends Table 27. Flu (Influenza) Vaccine Industry Drivers Table 28. Flu (Influenza) Vaccine Industry Opportunities and Challenges Table 29. Flu (Influenza) Vaccine Industry Restraints Table 30. Global Flu (Influenza) Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Flu (Influenza) Vaccine Revenue Market Share by Company (2021-2026) Table 32. Global Flu (Influenza) Vaccine Sales by Company (2021-2026) & (K Units) Table 33. Global Flu (Influenza) Vaccine Sales Share by Company (2021-2026) Table 34. Global Flu (Influenza) Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Flu (Influenza) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Flu (Influenza) Vaccine Major Company Production Sites and Headquarters Table 37. Global Flu (Influenza) Vaccine Company, Product Type & Application Table 38. Global Flu (Influenza) Vaccine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Flu (Influenza) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Flu (Influenza) Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Flu (Influenza) Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Flu (Influenza) Vaccine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Flu (Influenza) Vaccine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Flu (Influenza) Vaccine Sales Market Share in Value by Region (2021-2026) Table 46. Global Flu (Influenza) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Flu (Influenza) Vaccine Sales by Region (2027-2032) & (K Units) Table 48. Global Flu (Influenza) Vaccine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Flu (Influenza) Vaccine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Flu (Influenza) Vaccine Sales Market Share in Value by Region (2027-2032) Table 51. Global Flu (Influenza) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Flu (Influenza) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 54. Global Flu (Influenza) Vaccine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Flu (Influenza) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Flu (Influenza) Vaccine Sales Market Share in Value by Application (2021-2026) Table 57. Global Flu (Influenza) Vaccine Price by Application (2021-2026) & (US$/Unit) Table 58. Global Flu (Influenza) Vaccine Sales by Application (2027-2032) & (K Units) Table 59. Global Flu (Influenza) Vaccine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Flu (Influenza) Vaccine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Flu (Influenza) Vaccine Sales Market Share in Value by Application (2027-2032) Table 62. Global Flu (Influenza) Vaccine Price by Application (2027-2032) & (US$/Unit) Table 63. North America Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 64. North America Flu (Influenza) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Europe Flu (Influenza) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Flu (Influenza) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Latin America Flu (Influenza) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Flu (Influenza) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 73. Adimmune Company Information Table 74. Adimmune Business Overview Table 75. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Adimmune Flu (Influenza) Vaccine Product Portfolio Table 77. Adimmune Recent Development Table 78. Aimei Hissen Company Information Table 79. Aimei Hissen Business Overview Table 80. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Aimei Hissen Flu (Influenza) Vaccine Product Portfolio Table 82. Aimei Hissen Recent Development Table 83. Aleph Biomedical Company Information Table 84. Aleph Biomedical Business Overview Table 85. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Aleph Biomedical Flu (Influenza) Vaccine Product Portfolio Table 87. Aleph Biomedical Recent Development Table 88. CCBIO Company Information Table 89. CCBIO Business Overview Table 90. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. CCBIO Flu (Influenza) Vaccine Product Portfolio Table 92. CCBIO Recent Development Table 93. Changsheng Biological Company Information Table 94. Changsheng Biological Business Overview Table 95. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Changsheng Biological Flu (Influenza) Vaccine Product Portfolio Table 97. Changsheng Biological Recent Development Table 98. Hualan Bio Company Information Table 99. Hualan Bio Business Overview Table 100. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hualan Bio Flu (Influenza) Vaccine Product Portfolio Table 102. Hualan Bio Recent Development Table 103. Simcere Vaxtec Company Information Table 104. Simcere Vaxtec Business Overview Table 105. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolio Table 107. Simcere Vaxtec Recent Development Table 108. SINOVAC Company Information Table 109. SINOVAC Business Overview Table 110. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. SINOVAC Flu (Influenza) Vaccine Product Portfolio Table 112. SINOVAC Recent Development Table 113. SIOBP Company Information Table 114. SIOBP Business Overview Table 115. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. SIOBP Flu (Influenza) Vaccine Product Portfolio Table 117. SIOBP Recent Development Table 118. Tianyuan Bio-pharma(Novartis) Company Information Table 119. Tianyuan Bio-pharma(Novartis) Business Overview Table 120. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolio Table 122. Tianyuan Bio-pharma(Novartis) Recent Development Table 123. ZYAK Company Information Table 124. ZYAK Business Overview Table 125. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. ZYAK Flu (Influenza) Vaccine Product Portfolio Table 127. ZYAK Recent Development Table 128. GSK Company Information Table 129. GSK Business Overview Table 130. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. GSK Flu (Influenza) Vaccine Product Portfolio Table 132. GSK Recent Development Table 133. SANOFI Company Information Table 134. SANOFI Business Overview Table 135. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. SANOFI Flu (Influenza) Vaccine Product Portfolio Table 137. SANOFI Recent Development Table 138. North America Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. North America Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 140. North America Flu (Influenza) Vaccine Sales Market Share by Country (2021-2026) Table 141. North America Flu (Influenza) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 142. North America Flu (Influenza) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 143. North America Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Flu (Influenza) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Flu (Influenza) Vaccine Market Share by Country (2021-2026) Table 146. North America Flu (Influenza) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Flu (Influenza) Vaccine Market Share Forecast by Country (2027-2032) Table 148. Europe Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Europe Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 150. Europe Flu (Influenza) Vaccine Sales Market Share by Country (2021-2026) Table 151. Europe Flu (Influenza) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 152. Europe Flu (Influenza) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Flu (Influenza) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Flu (Influenza) Vaccine Market Share by Country (2021-2026) Table 156. Europe Flu (Influenza) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Flu (Influenza) Vaccine Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 160. Asia-Pacific Flu (Influenza) Vaccine Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Flu (Influenza) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 162. Asia-Pacific Flu (Influenza) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Flu (Influenza) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Flu (Influenza) Vaccine Market Share by Country (2021-2026) Table 166. Asia-Pacific Flu (Influenza) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Flu (Influenza) Vaccine Market Share Forecast by Country (2027-2032) Table 168. Latin America Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Latin America Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 170. Latin America Flu (Influenza) Vaccine Sales Market Share by Country (2021-2026) Table 171. Latin America Flu (Influenza) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 172. Latin America Flu (Influenza) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Flu (Influenza) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Flu (Influenza) Vaccine Market Share by Country (2021-2026) Table 176. Latin America Flu (Influenza) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Flu (Influenza) Vaccine Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 180. Middle East and Africa Flu (Influenza) Vaccine Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Flu (Influenza) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 182. Middle East and Africa Flu (Influenza) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Flu (Influenza) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Flu (Influenza) Vaccine Market Share by Country (2021-2026) Table 186. Middle East and Africa Flu (Influenza) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Flu (Influenza) Vaccine Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Flu (Influenza) Vaccine Distributors List Table 191. Flu (Influenza) Vaccine Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Flu (Influenza) Vaccine Image Figure 2. Global Flu (Influenza) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flu (Influenza) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Flu (Influenza) Vaccine Sales (2021-2032) & (K Units) Figure 5. Subunit Influenza Vaccine Image Figure 6. Global Subunit Influenza Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Quadrivalent Influenza Vaccine Image Figure 8. Global Quadrivalent Influenza Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Split Influenza Vaccine Image Figure 10. Global Split Influenza Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Pandemic Influenza Vaccine Image Figure 12. Global Pandemic Influenza Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Flu (Influenza) Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Flu (Influenza) Vaccine Market Share by Type 2025 VS 2032 Figure 15. North America Flu (Influenza) Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. North America Flu (Influenza) Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Europe Flu (Influenza) Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Flu (Influenza) Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Flu (Influenza) Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Flu (Influenza) Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Flu (Influenza) Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Flu (Influenza) Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Flu (Influenza) Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Flu (Influenza) Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Flu (Influenza) Vaccine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. For Children (6 months to 3 years) Image Figure 28. Global For Children (6 months to 3 years) Sales YoY Growth (2021-2032) & (K Units) Figure 29. For Adults and Children over 3 years Image Figure 30. Global For Adults and Children over 3 years Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Flu (Influenza) Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Flu (Influenza) Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Flu (Influenza) Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Flu (Influenza) Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Flu (Influenza) Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Flu (Influenza) Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Flu (Influenza) Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Flu (Influenza) Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Flu (Influenza) Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Flu (Influenza) Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Flu (Influenza) Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Flu (Influenza) Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Flu (Influenza) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Flu (Influenza) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Flu (Influenza) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Flu (Influenza) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Flu (Influenza) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Flu (Influenza) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Flu (Influenza) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Flu (Influenza) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Flu (Influenza) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Flu (Influenza) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Flu (Influenza) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Flu (Influenza) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Flu (Influenza) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Flu (Influenza) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Flu (Influenza) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Flu (Influenza) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Flu (Influenza) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Flu (Influenza) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Flu (Influenza) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Flu (Influenza) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Flu (Influenza) Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Flu (Influenza) Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Subunit Influenza Vaccine
  • Quadrivalent Influenza Vaccine
  • Split Influenza Vaccine
  • Pandemic Influenza Vaccine
Applications
  • For Children (6 months to 3 years)
  • For Adults and Children over 3 years
Companies covered
  • Adimmune
  • Aimei Hissen
  • Aleph Biomedical
  • CCBIO
  • Changsheng Biological
  • Hualan Bio
  • Simcere Vaxtec
  • SINOVAC
  • SIOBP
  • Tianyuan Bio-pharma(Novartis)
  • ZYAK
  • GSK
  • SANOFI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Flu (Influenza) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Flu (Influenza) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Flu (Influenza) Vaccine Market by Type
  6. 1.3.1 Subunit Influenza Vaccine
  7. 1.3.2 Quadrivalent Influenza Vaccine
  8. 1.3.3 Split Influenza Vaccine
  9. 1.3.4 Pandemic Influenza Vaccine
  10. 1.4 Global Flu (Influenza) Vaccine Market Size by Type
  11. 1.4.1 Global Flu (Influenza) Vaccine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Flu (Influenza) Vaccine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Flu (Influenza) Vaccine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Flu (Influenza) Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Flu (Influenza) Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Flu (Influenza) Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Flu (Influenza) Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Flu (Influenza) Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Flu (Influenza) Vaccine Industry Trends
  2. 2.2 Flu (Influenza) Vaccine Industry Drivers
  3. 2.3 Flu (Influenza) Vaccine Industry Opportunities and Challenges
  4. 2.4 Flu (Influenza) Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Flu (Influenza) Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Flu (Influenza) Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Flu (Influenza) Vaccine Price (2021-2026)
  4. 3.4 Global Flu (Influenza) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Flu (Influenza) Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Flu (Influenza) Vaccine Company, Product Type & Application
  7. 3.7 Global Flu (Influenza) Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Flu (Influenza) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Flu (Influenza) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Flu (Influenza) Vaccine Tier 1, Tier 2, and Tier 3
4 Flu (Influenza) Vaccine Regional Status and Outlook
  1. 4.1 Global Flu (Influenza) Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Flu (Influenza) Vaccine Historic Market Size by Region
  3. 4.2.1 Global Flu (Influenza) Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Flu (Influenza) Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Flu (Influenza) Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Flu (Influenza) Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Flu (Influenza) Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Flu (Influenza) Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Flu (Influenza) Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Flu (Influenza) Vaccine by Application
  1. 5.1 Flu (Influenza) Vaccine Market by Application
  2. 5.1.1 For Children (6 months to 3 years)
  3. 5.1.2 For Adults and Children over 3 years
  4. 5.2 Global Flu (Influenza) Vaccine Market Size by Application
  5. 5.2.1 Global Flu (Influenza) Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Flu (Influenza) Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Flu (Influenza) Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Flu (Influenza) Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Flu (Influenza) Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Flu (Influenza) Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Flu (Influenza) Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Flu (Influenza) Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Adimmune
  2. 6.1.1 Adimmune Company Information
  3. 6.1.2 Adimmune Business Overview
  4. 6.1.3 Adimmune Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Adimmune Flu (Influenza) Vaccine Product Portfolio
  6. 6.1.5 Adimmune Recent Developments
  7. 6.2 Aimei Hissen
  8. 6.2.1 Aimei Hissen Company Information
  9. 6.2.2 Aimei Hissen Business Overview
  10. 6.2.3 Aimei Hissen Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aimei Hissen Flu (Influenza) Vaccine Product Portfolio
  12. 6.2.5 Aimei Hissen Recent Developments
  13. 6.3 Aleph Biomedical
  14. 6.3.1 Aleph Biomedical Company Information
  15. 6.3.2 Aleph Biomedical Business Overview
  16. 6.3.3 Aleph Biomedical Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aleph Biomedical Flu (Influenza) Vaccine Product Portfolio
  18. 6.3.5 Aleph Biomedical Recent Developments
  19. 6.4 CCBIO
  20. 6.4.1 CCBIO Company Information
  21. 6.4.2 CCBIO Business Overview
  22. 6.4.3 CCBIO Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CCBIO Flu (Influenza) Vaccine Product Portfolio
  24. 6.4.5 CCBIO Recent Developments
  25. 6.5 Changsheng Biological
  26. 6.5.1 Changsheng Biological Company Information
  27. 6.5.2 Changsheng Biological Business Overview
  28. 6.5.3 Changsheng Biological Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Changsheng Biological Flu (Influenza) Vaccine Product Portfolio
  30. 6.5.5 Changsheng Biological Recent Developments
  31. 6.6 Hualan Bio
  32. 6.6.1 Hualan Bio Company Information
  33. 6.6.2 Hualan Bio Business Overview
  34. 6.6.3 Hualan Bio Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hualan Bio Flu (Influenza) Vaccine Product Portfolio
  36. 6.6.5 Hualan Bio Recent Developments
  37. 6.7 Simcere Vaxtec
  38. 6.7.1 Simcere Vaxtec Company Information
  39. 6.7.2 Simcere Vaxtec Business Overview
  40. 6.7.3 Simcere Vaxtec Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolio
  42. 6.7.5 Simcere Vaxtec Recent Developments
  43. 6.8 SINOVAC
  44. 6.8.1 SINOVAC Company Information
  45. 6.8.2 SINOVAC Business Overview
  46. 6.8.3 SINOVAC Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 SINOVAC Flu (Influenza) Vaccine Product Portfolio
  48. 6.8.5 SINOVAC Recent Developments
  49. 6.9 SIOBP
  50. 6.9.1 SIOBP Company Information
  51. 6.9.2 SIOBP Business Overview
  52. 6.9.3 SIOBP Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 SIOBP Flu (Influenza) Vaccine Product Portfolio
  54. 6.9.5 SIOBP Recent Developments
  55. 6.10 Tianyuan Bio-pharma(Novartis)
  56. 6.10.1 Tianyuan Bio-pharma(Novartis) Company Information
  57. 6.10.2 Tianyuan Bio-pharma(Novartis) Business Overview
  58. 6.10.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolio
  60. 6.10.5 Tianyuan Bio-pharma(Novartis) Recent Developments
  61. 6.11 ZYAK
  62. 6.11.1 ZYAK Company Information
  63. 6.11.2 ZYAK Business Overview
  64. 6.11.3 ZYAK Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ZYAK Flu (Influenza) Vaccine Product Portfolio
  66. 6.11.5 ZYAK Recent Developments
  67. 6.12 GSK
  68. 6.12.1 GSK Company Information
  69. 6.12.2 GSK Business Overview
  70. 6.12.3 GSK Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 GSK Flu (Influenza) Vaccine Product Portfolio
  72. 6.12.5 GSK Recent Developments
  73. 6.13 SANOFI
  74. 6.13.1 SANOFI Company Information
  75. 6.13.2 SANOFI Business Overview
  76. 6.13.3 SANOFI Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 SANOFI Flu (Influenza) Vaccine Product Portfolio
  78. 6.13.5 SANOFI Recent Developments
7 North America by Country
  1. 7.1 North America Flu (Influenza) Vaccine Sales by Country
  2. 7.1.1 North America Flu (Influenza) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Flu (Influenza) Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Flu (Influenza) Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Flu (Influenza) Vaccine Market Size by Country
  6. 7.2.1 North America Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Flu (Influenza) Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Flu (Influenza) Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Flu (Influenza) Vaccine Sales by Country
  2. 8.1.1 Europe Flu (Influenza) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Flu (Influenza) Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Flu (Influenza) Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Flu (Influenza) Vaccine Market Size by Country
  6. 8.2.1 Europe Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Flu (Influenza) Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Flu (Influenza) Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Flu (Influenza) Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Flu (Influenza) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Flu (Influenza) Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Flu (Influenza) Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Flu (Influenza) Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Flu (Influenza) Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Flu (Influenza) Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Flu (Influenza) Vaccine Sales by Country
  2. 10.1.1 South America Flu (Influenza) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Flu (Influenza) Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Flu (Influenza) Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Flu (Influenza) Vaccine Market Size by Country
  6. 10.2.1 South America Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Flu (Influenza) Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Flu (Influenza) Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Flu (Influenza) Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Flu (Influenza) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Flu (Influenza) Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Flu (Influenza) Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Flu (Influenza) Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Flu (Influenza) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Flu (Influenza) Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Flu (Influenza) Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Flu (Influenza) Vaccine Value Chain Analysis
  2. 12.1.1 Flu (Influenza) Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Flu (Influenza) Vaccine Production Mode & Process
  7. 12.2 Flu (Influenza) Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Flu (Influenza) Vaccine Distributors
  10. 12.2.3 Flu (Influenza) Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst